Literature DB >> 15345714

Polyglutamine expansion in ataxin-3 does not affect protein stability: implications for misfolding and disease.

Michelle K M Chow1, Andrew M Ellisdon, Lisa D Cabrita, Stephen P Bottomley.   

Abstract

Polyglutamine proteins that cause neurodegenerative disease are known to form proteinaceous aggregates, such as nuclear inclusions, in the neurons of affected patients. Although polyglutamine proteins have been shown to form fibrillar aggregates in a variety of contexts, the mechanisms underlying the aberrant conformational changes and aggregation are still not well understood. In this study, we have investigated the hypothesis that polyglutamine expansion in the protein ataxin-3 destabilizes the native protein, leading to the accumulation of a partially unfolded, aggregation-prone intermediate. To examine the relationship between polyglutamine length and native state stability, we produced and analyzed three ataxin-3 variants containing 15, 28, and 50 residues in their respective glutamine tracts. At pH 7.4 and 37 degrees C, Atax3(Q50), which lies within the pathological range, formed fibrils significantly faster than the other proteins. Somewhat surprisingly, we observed no difference in the acid-induced equilibrium and kinetic un/folding transitions of all three proteins, which indicates that the stability of the native conformation was not affected by polyglutamine tract extension. This has led us to reconsider the mechanisms and factors involved in ataxin-3 misfolding, and we have developed a new model for the aggregation process in which the pathways of un/folding and misfolding are distinct and separate. Furthermore, given that native state stability is unaffected by polyglutamine length, we consider the possible role and influence of other factors in the fibrillization of ataxin-3.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15345714     DOI: 10.1074/jbc.M405799200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence.

Authors:  Ronald Wetzel
Journal:  J Mol Biol       Date:  2012-01-27       Impact factor: 5.469

2.  Amyloid formation of a protein in the absence of initial unfolding and destabilization of the native state.

Authors:  Gemma Soldi; Francesco Bemporad; Silvia Torrassa; Annalisa Relini; Matteo Ramazzotti; Niccolò Taddei; Fabrizio Chiti
Journal:  Biophys J       Date:  2005-09-16       Impact factor: 4.033

Review 3.  Amyloid formation by globular proteins under native conditions.

Authors:  Fabrizio Chiti; Christopher M Dobson
Journal:  Nat Chem Biol       Date:  2009-01       Impact factor: 15.040

4.  Separating instability from aggregation propensity in γS-crystallin variants.

Authors:  William D Brubaker; J Alfredo Freites; Kory J Golchert; Rebecca A Shapiro; Vasilios Morikis; Douglas J Tobias; Rachel W Martin
Journal:  Biophys J       Date:  2011-01-19       Impact factor: 4.033

5.  Small heat-shock proteins interact with a flanking domain to suppress polyglutamine aggregation.

Authors:  Amy L Robertson; Stephen J Headey; Helen M Saunders; Heath Ecroyd; Martin J Scanlon; John A Carver; Stephen P Bottomley
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-19       Impact factor: 11.205

6.  Location trumps length: polyglutamine-mediated changes in folding and aggregation of a host protein.

Authors:  Matthew D Tobelmann; Regina M Murphy
Journal:  Biophys J       Date:  2011-06-08       Impact factor: 4.033

7.  Functional insights from the distribution and role of homopeptide repeat-containing proteins.

Authors:  Noel G Faux; Stephen P Bottomley; Arthur M Lesk; James A Irving; John R Morrison; Maria Garcia de la Banda; James C Whisstock
Journal:  Genome Res       Date:  2005-04       Impact factor: 9.043

Review 8.  A novel therapeutic strategy for polyglutamine diseases by stabilizing aggregation-prone proteins with small molecules.

Authors:  Motomasa Tanaka; Yoko Machida; Nobuyuki Nukina
Journal:  J Mol Med (Berl)       Date:  2005-03-10       Impact factor: 4.599

9.  Interaction of selected divalent metal ions with human ataxin-3 Q36.

Authors:  Iwona Stawoska; Aleksandra Wesełucha-Birczyńska; Maria Elena Regonesi; Matteo Riva; Paolo Tortora; Grazyna Stochel
Journal:  J Biol Inorg Chem       Date:  2009-07-04       Impact factor: 3.358

10.  In vivo suppression of polyglutamine neurotoxicity by C-terminus of Hsp70-interacting protein (CHIP) supports an aggregation model of pathogenesis.

Authors:  Aislinn J Williams; Tina M Knutson; Veronica F Colomer Gould; Henry L Paulson
Journal:  Neurobiol Dis       Date:  2008-11-08       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.